Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
PurposeAlthough the treatment of advanced melanoma patients with immune checkpoint inhibitors (ICI) significantly increased the therapeutic efficiency, many patients remain resistant to ICI that could be due to immunosuppression mediated by myeloid-derived suppressor cells (MDSC). These cells are en...
Main Authors: | Vera Petrova, Christopher Groth, Rebekka Bitsch, Ihor Arkhypov, Sonja C. S. Simon, Svetlana Hetjens, Verena Müller, Jochen Utikal, Viktor Umansky |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1065767/full |
Similar Items
-
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
by: Vera Petrova, et al.
Published: (2020-03-01) -
Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
by: Ihor Arkhypov, et al.
Published: (2020-08-01) -
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
by: Alisa Lepper, et al.
Published: (2023-12-01) -
Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
by: Christopher Groth, et al.
Published: (2021-02-01) -
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
by: Wei Li, et al.
Published: (2022-09-01)